Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir is a research paper published in Antiviral Therapy (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Boston University Clinical HIV/AIDS Research Training Program
Grant: T32AI052074